| Title: |
Beyond the Numbers: Reframing Uric Acid Elevations in Bempedoic Acid Therapy |
| Authors: |
Fogacci F; Borghi C; Cicero AFG |
| Contributors: |
Fogacci, F; Borghi, C; Cicero, Arrigo Francesco Giuseppe |
| Publication Year: |
2025 |
| Collection: |
IRIS Università degli Studi di Bologna (CRIS - Current Research Information System) |
| Subject Terms: |
Uric acid; bempedoic acid; xanthine oxidase |
| Description: |
We read with great interest the brief report by Prof. Ray et al on the association between uric acid– lowering therapies and gout incidence among patients treated with bempedoic acid in the CLEAR (Cholesterol LowEring via bempedoic acid, an ACLinhibiting Regimen) Outcomes trial.1 The authors are to be commended for addressing an often-overlooked metabolic aspect of bempedoic acid therapy and for providing valuable insights into the management of hyperuricemia in this population. We would like to offer a few considerations that may further contextualize and expand the clinical interpretation of these findings |
| Document Type: |
article in journal/newspaper |
| File Description: |
ELETTRONICO |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/41421014; info:eu-repo/semantics/altIdentifier/wos/WOS:001650533800002; volume:5; issue:1; firstpage:1; lastpage:2; numberofpages:2; journal:JACC. ADVANCES; https://hdl.handle.net/11585/1050377; https://www.sciencedirect.com/science/article/pii/S2772963X25009111 |
| DOI: |
10.1016/j.jacadv.2025.102482 |
| Availability: |
https://hdl.handle.net/11585/1050377; https://doi.org/10.1016/j.jacadv.2025.102482; https://www.sciencedirect.com/science/article/pii/S2772963X25009111 |
| Rights: |
info:eu-repo/semantics/openAccess ; license:Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY) ; license uri:iris.PUB15 |
| Accession Number: |
edsbas.96F20EB7 |
| Database: |
BASE |